Kenji Tsuchihashi

8PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Molecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|Nov 08, 2025
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Aya Takigawa, Kenji Tsuchihashi, Kenta Nio

|Jul 08, 2025
Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.

Takafumi Kitazono, Taichi Isobe, Satoshi Nishiyori

|Oct 10, 2024
Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study.

Kanami Furukawa, Hirofumi Ohmura, Shohei Moriyama

|May 15, 2024
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.

Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe

|Apr 05, 2024
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.

Mamoru Ito, Yuta Okumura, Kenta Nio

Pageof 2

Frequent Collaborators

3 joint publications

Mamoru Ito

3 joint publications

Kyoko Yamaguchi

2 joint publications

Takafumi Kitazono

2 joint publications

Eishi Baba